Cargando…
Collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma development
Neuroblastoma is the most common extracranial solid tumour in children and is histologically classified by its Schwannian stromal cells. Although having fewer Schwannian stromal cells is generally associated with more aggressive phenotypes, the exact roles of other stromal cells (mainly macrophages...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095779/ https://www.ncbi.nlm.nih.gov/pubmed/27425378 http://dx.doi.org/10.1002/path.4769 |
_version_ | 1782465346004844544 |
---|---|
author | Hashimoto, Okito Yoshida, Makiko Koma, Yu‐ichiro Yanai, Tomoko Hasegawa, Daiichiro Kosaka, Yoshiyuki Nishimura, Noriyuki Yokozaki, Hiroshi |
author_facet | Hashimoto, Okito Yoshida, Makiko Koma, Yu‐ichiro Yanai, Tomoko Hasegawa, Daiichiro Kosaka, Yoshiyuki Nishimura, Noriyuki Yokozaki, Hiroshi |
author_sort | Hashimoto, Okito |
collection | PubMed |
description | Neuroblastoma is the most common extracranial solid tumour in children and is histologically classified by its Schwannian stromal cells. Although having fewer Schwannian stromal cells is generally associated with more aggressive phenotypes, the exact roles of other stromal cells (mainly macrophages and fibroblasts) are unclear. Here, we examined 41 cases of neuroblastoma using immunohistochemistry for the tumour‐associated macrophage (TAM) markers CD68, CD163, and CD204, and a cancer‐associated fibroblast (CAF) marker, alpha smooth muscle actin (αSMA). Each case was assigned to low/high groups on the basis of the number of TAMs or three groups on the basis of the αSMA‐staining area for CAFs. Both the number of TAMs and the area of CAFs were significantly correlated with clinical stage, MYCN amplification, bone marrow metastasis, histological classification, histological type, and risk classification. Furthermore, TAM settled in the vicinity of the CAF area, suggesting their close interaction within the tumour microenvironment. We next determined the effects of conditioned medium of a neuroblastoma cell line (NBCM) on bone marrow‐derived mesenchymal stem cells (BM‐MSCs) and peripheral blood mononuclear cell (PBMC)‐derived macrophages in vitro. The TAM markers CD163 and CD204 were significantly up‐regulated in PBMC‐derived macrophages treated with NBCM. The expression of αSMA by BM‐MSCs was increased in NBCM‐treated cells. Co‐culturing with CAF‐like BM‐MSCs did not enhance the invasive ability but supported the proliferation of tumour cells, whereas tumour cells co‐cultured with TAM‐like macrophages had the opposite effect. Intriguingly, TAM‐like macrophages enhanced not only the invasive abilities of tumour cells and BM‐MSCs but also the proliferation of BM‐MSCs. CXCL2 secreted from TAM‐like macrophages plays an important role in tumour invasiveness. Taken together, these results indicate that PBMC‐derived macrophages and BM‐MSCs are recruited to a tumour site and activated into TAMs and CAFs, respectively, followed by the formation of favourable environments for neuroblastoma progression. © 2016 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland. |
format | Online Article Text |
id | pubmed-5095779 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley & Sons, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-50957792016-11-09 Collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma development Hashimoto, Okito Yoshida, Makiko Koma, Yu‐ichiro Yanai, Tomoko Hasegawa, Daiichiro Kosaka, Yoshiyuki Nishimura, Noriyuki Yokozaki, Hiroshi J Pathol Original Papers Neuroblastoma is the most common extracranial solid tumour in children and is histologically classified by its Schwannian stromal cells. Although having fewer Schwannian stromal cells is generally associated with more aggressive phenotypes, the exact roles of other stromal cells (mainly macrophages and fibroblasts) are unclear. Here, we examined 41 cases of neuroblastoma using immunohistochemistry for the tumour‐associated macrophage (TAM) markers CD68, CD163, and CD204, and a cancer‐associated fibroblast (CAF) marker, alpha smooth muscle actin (αSMA). Each case was assigned to low/high groups on the basis of the number of TAMs or three groups on the basis of the αSMA‐staining area for CAFs. Both the number of TAMs and the area of CAFs were significantly correlated with clinical stage, MYCN amplification, bone marrow metastasis, histological classification, histological type, and risk classification. Furthermore, TAM settled in the vicinity of the CAF area, suggesting their close interaction within the tumour microenvironment. We next determined the effects of conditioned medium of a neuroblastoma cell line (NBCM) on bone marrow‐derived mesenchymal stem cells (BM‐MSCs) and peripheral blood mononuclear cell (PBMC)‐derived macrophages in vitro. The TAM markers CD163 and CD204 were significantly up‐regulated in PBMC‐derived macrophages treated with NBCM. The expression of αSMA by BM‐MSCs was increased in NBCM‐treated cells. Co‐culturing with CAF‐like BM‐MSCs did not enhance the invasive ability but supported the proliferation of tumour cells, whereas tumour cells co‐cultured with TAM‐like macrophages had the opposite effect. Intriguingly, TAM‐like macrophages enhanced not only the invasive abilities of tumour cells and BM‐MSCs but also the proliferation of BM‐MSCs. CXCL2 secreted from TAM‐like macrophages plays an important role in tumour invasiveness. Taken together, these results indicate that PBMC‐derived macrophages and BM‐MSCs are recruited to a tumour site and activated into TAMs and CAFs, respectively, followed by the formation of favourable environments for neuroblastoma progression. © 2016 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland. John Wiley & Sons, Ltd 2016-09-19 2016-10 /pmc/articles/PMC5095779/ /pubmed/27425378 http://dx.doi.org/10.1002/path.4769 Text en © 2016 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Papers Hashimoto, Okito Yoshida, Makiko Koma, Yu‐ichiro Yanai, Tomoko Hasegawa, Daiichiro Kosaka, Yoshiyuki Nishimura, Noriyuki Yokozaki, Hiroshi Collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma development |
title | Collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma development |
title_full | Collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma development |
title_fullStr | Collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma development |
title_full_unstemmed | Collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma development |
title_short | Collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma development |
title_sort | collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma development |
topic | Original Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095779/ https://www.ncbi.nlm.nih.gov/pubmed/27425378 http://dx.doi.org/10.1002/path.4769 |
work_keys_str_mv | AT hashimotookito collaborationofcancerassociatedfibroblastsandtumourassociatedmacrophagesforneuroblastomadevelopment AT yoshidamakiko collaborationofcancerassociatedfibroblastsandtumourassociatedmacrophagesforneuroblastomadevelopment AT komayuichiro collaborationofcancerassociatedfibroblastsandtumourassociatedmacrophagesforneuroblastomadevelopment AT yanaitomoko collaborationofcancerassociatedfibroblastsandtumourassociatedmacrophagesforneuroblastomadevelopment AT hasegawadaiichiro collaborationofcancerassociatedfibroblastsandtumourassociatedmacrophagesforneuroblastomadevelopment AT kosakayoshiyuki collaborationofcancerassociatedfibroblastsandtumourassociatedmacrophagesforneuroblastomadevelopment AT nishimuranoriyuki collaborationofcancerassociatedfibroblastsandtumourassociatedmacrophagesforneuroblastomadevelopment AT yokozakihiroshi collaborationofcancerassociatedfibroblastsandtumourassociatedmacrophagesforneuroblastomadevelopment |